These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21494805)

  • 21. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
    Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
    Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
    Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
    Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
    J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies.
    Soejima K; Nakagaki T
    Semin Hematol; 2005 Jan; 42(1):56-62. PubMed ID: 15662617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Doddapattar P; Dhanesha N; Chorawala MR; Tinsman C; Jain M; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):520-528. PubMed ID: 29348121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins.
    André P; Denis CV; Ware J; Saffaripour S; Hynes RO; Ruggeri ZM; Wagner DD
    Blood; 2000 Nov; 96(10):3322-8. PubMed ID: 11071623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet physiology and thrombosis.
    Andrews RK; Berndt MC
    Thromb Res; 2004; 114(5-6):447-53. PubMed ID: 15507277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on ADAMTS13 and VWF in cardiovascular and hematological disorders.
    Akyol O; Akyol S; Chen CH
    Clin Chim Acta; 2016 Dec; 463():109-118. PubMed ID: 27746209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Platelet--vessel wall interactions].
    Baruch D
    Therapie; 2006; 61(5):371-8. PubMed ID: 17243265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADAMTS13: a new link between thrombosis and inflammation.
    Chauhan AK; Kisucka J; Brill A; Walsh MT; Scheiflinger F; Wagner DD
    J Exp Med; 2008 Sep; 205(9):2065-74. PubMed ID: 18695007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers.
    Casonato A; Pontara E; Bertomoro A; Zucchetto S; Zerbinati P; Girolami A
    J Lab Clin Med; 1997 Feb; 129(2):251-9. PubMed ID: 9016863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation and breakdown of soluble ultralarge von Willebrand factor multimers.
    Turner N; Nolasco L; Moake J
    Semin Thromb Hemost; 2012 Feb; 38(1):38-46. PubMed ID: 22314602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    George JN
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress.
    Shim K; Anderson PJ; Tuley EA; Wiswall E; Sadler JE
    Blood; 2008 Jan; 111(2):651-7. PubMed ID: 17901248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of von Willebrand factor multimer size and implications for disease.
    Pimanda J; Hogg P
    Blood Rev; 2002 Sep; 16(3):185-92. PubMed ID: 12163004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo.
    De Maeyer B; De Meyer SF; Feys HB; Pareyn I; Vandeputte N; Deckmyn H; Vanhoorelbeke K
    J Thromb Haemost; 2010 Oct; 8(10):2305-12. PubMed ID: 20695979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombosis and von Willebrand Factor.
    Shahidi M
    Adv Exp Med Biol; 2017; 906():285-306. PubMed ID: 27628010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein B100/Low-Density Lipoprotein Regulates Proteolysis and Functions of von Willebrand Factor under Arterial Shear.
    Cao W; Abdelgawwad MS; Li J; Zheng XL
    Thromb Haemost; 2019 Dec; 119(12):1933-1946. PubMed ID: 31493779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.
    Donadelli R; Orje JN; Capoferri C; Remuzzi G; Ruggeri ZM
    Blood; 2006 Mar; 107(5):1943-50. PubMed ID: 16293606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.
    Tati R; Kristoffersson AC; Manea Hedström M; Mörgelin M; Wieslander J; van Kooten C; Karpman D
    EBioMedicine; 2017 Feb; 16():302-311. PubMed ID: 28139439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.